Dual X-ray Absorptiometry in Today's Clinical Practice

Radiologic Clinics of North America

Volumn 48, Issue 3, 2010, Pages 541-560

  Dasher, Lance G ^a   Newton, Christopher D ^a   Lenchik, Leon ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Absorptiometry; DXA; FRAX; Osteoporosis

Indexed keywords

ARTIFACT; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CLINICAL ASSESSMENT TOOL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FRAGILITY FRACTURE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; LUMBAR SPINE; OSTEOPENIA; OSTEOPOROSIS; PATIENT POSITIONING; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SECONDARY OSTEOPOROSIS; SENSITIVITY AND SPECIFICITY; VERTEBRA FRACTURE; METHODOLOGY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; RISK FACTOR; SPINE;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; HUMANS; OSTEOPOROSIS; RISK FACTORS; SPINE;

EID: 77954171802     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2010.02.019     Document Type: Review

References (62)

1. Guglielmi G., de Terlizzi F. Quantitative ultrasound in the assessment of osteoporosis. Eur J Radiol 2009, 71:425-431.
2. Adams J.E. Quantitative computed tomography. Eur J Radiol 2009, 71:415-424.
3. Blake G.M., Fogelman I. The clinical role of dual energy X-ray absorptiometry. Eur J Radiol 2009, 71:406-414.
4. Grampp S., Genant H.K., Mathur A., et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997, 12:697-711.
5. Lewis M.K., Blake G.M., Fogelman I. Patient dose in dual x-ray absorptiometry. Osteoporos Int 1994, 4:11-15.
6. Njeh C.F., Fuerst T., Hans D., et al. Radiation exposure in bone mineral density assessment. Appl Radiat Isot 1999, 50:215-236.
7. Blake G.M., Naeem M., Boutros M. Comparison of effective dose to children and adults from dual X-ray absorptiometry examinations. Bone 2006, 38:935-942.
8. Guglielmi G., Gluer C.C., Majumdar S., et al. Current methods and advances in bone densitometry. Eur Radiol 1995, 5:129-139.
9. Grampp S., Jergas M., Glüer C.C., et al. Radiologic diagnosis of osteoporosis. Current methods and perspectives. Radiol Clin North Am 1993, 31:1133-1145.
10. Blake G.M., Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997, 27:210-228.
11. Lewiecki E.M., Gordon C.M., Baim S., et al. International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone 2008, 43:1115-1121.
12. Binkley N., Bilezikian J.P., Kendler D.L., et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2005 position development conference. J Clin Densitom 2006, 9:4-14.
13. Lenchik L., Leib E.S., Hamdy R.C., et al. International Society for Clinical Densitometry Position Development Panel and Scientific Advisory Committee. Executive summary International Society for Clinical Densitometry position development conference Denver, Colorado July 20-22, 2001. J Clin Densitom 2002, 5(Suppl):S1-S3.
14. Miller P.D., Bonnick S.L., Rosen C.J., et al. Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum 1996, 25:361-372.
15. Svendsen O.L., Hassager C., Skodt V., et al. Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip and forearm: a human cadaver study. J Bone Miner Res 1995, 10:868-873.
16. Blake G.M., Fogelman I. How important are BMD accuracy errors for the clinical interpretation of DXA scans?. J Bone Miner Res 2008, 23:457-462.
17. Tothill P., Hannan J. Precision and accuracy errors of measuring changes in bone mineral density by dual-energy X-ray absorptiometry. Osteoporos Int 2007, 18:1515-1523.
18. Bonnick S.L., Johnston C.C., Kleerekoper M., et al. Importance of precision in bone density measurements. J Clin Densitom 2001, 4:105-110.
19. Kiebzak G.M., Faulkner K.G., Wacker W., et al. Effect of precision error on T-scores and diagnostic classification of bone status. J Clin Densitom 2007, 10:239-243.
20. Blake G.M., Herd R.J.M., Fogelman I. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporos Int 1996, 16:462-470.
21. Patel R., Blake G.M., Rymer J., et al. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 2000, 11:68-75.
22. Engelke K., Glüer C.C. Quality and performance measures in bone densitometry: part 1: errors and diagnosis. Osteoporos Int 2006, 17:1283-1292.
23. Courtney A.C., Wachtel E.F., Myers E.R., et al. Age-related reductions in the strength of the femur tested in a fall-loading configuration. J Bone Joint Surg Am 1995, 77:387-395.
24. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
25. Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005, 20:1185-1194.
26. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. Lancet 1993, 341:72-75.
27. Stone K.L., Seeley D.G., Lui L.Y., et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003, 18:1947-1954.
28. Binkovitz L.A., Henwood M.J., Sparke P. Pediatric dual-energy X-ray absorptiometry: technique, interpretation, and clinical applications. Semin Nucl Med 2007, 37:303-313.
29. Kanis J.A., Melton L., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
30. Kanis J.A., Delmas P., Burckhardt P., et al. Guidelines for diagnosis and treatment of osteoporosis. Osteoporos Int 1997, 7:390-406.
31. Genant H.K., Cooper C., Poor G., et al. Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 1999, 10:259-264.
32. Kanis J.A., Gluer C.C. An update on the diagnosis and assessment of osteoporosis with densitometry: committee of scientific advisors, International Osteoporosis Foundation. Osteoporos Int 2000, 11:192-202.
33. Rosen C.J. Issues facing bone densitometry in the new century: reflections from the National Institutes of Health consensus development conference on osteoporosis. Clin Densitom 2000, 3:211-213.
34. US Preventive Services Task Force Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002, 137:526-528.
35. Hodgson S.F., Watts N.B., Bilezikian J.P., et al. AACE osteoporosis task force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003, 9:544-564.
36. Compston J. US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences. Curr Rheumatol Rep 2004, 6:66-69.
37. Kornbluth A., Hayes M., Feldman S., et al. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol 2006, 101:1546-1550.
38. Baddoura R., Awada H., Okais J., et al. An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines. Osteoporos Int 2006, 17:1111-1115.
39. Zethraeus N., Borgstrom F., Strom O., et al. Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 2007, 18:9-23.
40. Liu H., Paige N.M., Goldzweig C.L., et al. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med 2008, 148:685-701.
41. Lim L.S., Hoeksema L.J., Sherin K., ACPM prevention practice committee Screening for osteoporosis in the adult US population: ACPM position statement on preventive practice. Am J Prev Med 2009, 36:366-375.
42. Dawson-Hughes B., Looker A.C., Tosteson A.N., et al. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int 2010, 21:41-52.
43. Melton L.J., Chrischilles E.A., Cooper C., et al. How many women have osteoporosis?. J Bone Miner Res 1992, 7:1005-1010.
44. Melton L.J. The prevalence of osteoporosis. J Bone Miner Res 1997, 12:1769-1771.
45. Baim S., Leonard M.B., Bianchi M.L., et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 2008, 11:6-21.
46. Kanis J.A., Johnell O., Oden A., et al. Ten-year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001, 12:989-995.
47. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:1033-1046.
48. Borgstrom F., Johnell O., Kanis J.A., et al. At what hip fracture risk is it cost effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int 2006, 17:1459-1471.
49. Kanis J., Oden A., Johansson H., et al. FRAX and its applications to clinical practice. Bone 2009, 44:734-743.
50. Watts N., Lewieki E., Miller P., et al. National Osteoporosis Foundation 2008 clinician's guide to prevention and treatment of osteoporosis and the World Health Organization fracture risk assessment tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom 2008, 11:473-477.
51. El Maghraoui A., Achemlal L., Bezza A. Monitoring of dual-energy X-ray absorptiometry measurement in clinical practice. J Clin Densitom 2006, 9:281-286.
52. Lenchik L., Kiebzak G.M., Blunt B.A. International Society for Clinical Densitometry position development panel and scientific advisory committee. What is the role of serial bone mineral density measurements in patient management?. J Clin Densitom 2002, 5(Suppl):S29-S38.
53. Schousboe J.T., Vokes T., Broy S.B., et al. Vertebral fracture assessment: the 2007 ISCD official positions. J Clin Densitom 2008, 11:92-108.
54. Fuerst T., Wu C., Genant H.K., et al. Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting. Osteoporos Int 2009, 20:1199-1205.
55. El Maghroui A., Roux C. DXA scanning in clinical practice. QJM 2008, 101:605-617.
56. Lenchik L., Rochmis P., Sartoris D.J. Optimized interpretation and reporting of dual X-ray absorptiometry (DXA) scans. AJR Am J Roentgenol 1998, 171:1509-1520.
57. Watts N.B. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int 2004, 15:847-854.
58. Lentle B.C., Prior J.C. Osteoporosis: what a clinician expects to learn from a patient's bone density examination. Radiology 2003, 228:620-628.
59. National Osteoporosis Foundation Clinician's guide to prevention and treatment of osteoporosis 2008, National Osteoporosis Foundation, Washington, DC.
60. Weinstein L., Ullery B. Identification of at-risk women for osteoporosis screening. Am J Obstet Gynecol 2000, 183:547-549.
61. Ribot C., Tremollieres F., Pouilles J.M. Can we detect women with low bone mass using clinical risk factors?. Am J Med 1995, 98:52s-55s.
62. Tannenbaum C., Clark J., Schwartzman K., et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002, 87:4431-4437.